These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Menkes' disease: report of a case and determination of eumelanin and pheomelanin in hypopigmented hair. Tomita Y; Kondo Y; Ito S; Hara M; Yoshimura T; Igarashi H; Tagami H Dermatology; 1992; 185(1):66-8. PubMed ID: 1638075 [TBL] [Abstract][Full Text] [Related]
24. EPR spectroscopy of a clinically active (1:2) copper(II)-histidine complex used in the treatment of Menkes disease: a Fourier transform analysis of a fluid CW-EPR spectrum. Gala L; Lawson M; Jomova K; Zelenicky L; Congradyova A; Mazur M; Valko M Molecules; 2014 Jan; 19(1):980-91. PubMed ID: 24434671 [TBL] [Abstract][Full Text] [Related]
25. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Christodoulou J; Danks DM; Sarkar B; Baerlocher KE; Casey R; Horn N; Tümer Z; Clarke JT Am J Med Genet; 1998 Mar; 76(2):154-64. PubMed ID: 9511979 [TBL] [Abstract][Full Text] [Related]
26. The mild form of Menkes disease: progress report on the original case. Danks DM Am J Med Genet; 1988 Jul; 30(3):859-64. PubMed ID: 3189408 [No Abstract] [Full Text] [Related]
27. [Manufacturing and stability of copper-histidine solution for treatment of Menkes' Kinky Hair Syndrome]. Hoppe-Tichy T; Nguyen TH; Hentze BW; Lorke M Pharmazie; 2005 Mar; 60(3):205-7. PubMed ID: 15801674 [TBL] [Abstract][Full Text] [Related]
28. The failure of parenteral copper therapy in Menkes Kinky Hair syndrome. Garnica AD Eur J Pediatr; 1984 Jun; 142(2):98-102. PubMed ID: 6468439 [TBL] [Abstract][Full Text] [Related]
29. Insight into the gas-phase structure of a copper(II) L-histidine complex, the agent used to treat Menkes disease. Ziegler BE; Marta RA; Burt MB; McMahon TB Inorg Chem; 2014 Mar; 53(5):2349-51. PubMed ID: 24528202 [TBL] [Abstract][Full Text] [Related]